September 9, 2026
Analyst Bio:
IMAX (NYSE:IMAX ) had its price objective raised by stock analysts at Rosenblatt Securities from $60.00 to $65.00 in a report released on Wednesday, Benzinga reports. The brokerage presently has a "buy" rating on the stock. Rosenblatt Securities' target price would suggest a potential upside of 23.65% from the company's current price.



